We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Unfinished business

17 Dec 2021 By Robert Cyran

The software group might spend $30 bln on healthcare IT specialist Cerner. That would mark a shift from buying back $100 bln of stock in four years. But Cerner has been in Oracle’s sights for nearly 20 years. It’s the last company still available on a longstanding shopping list.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)